Request Demo
Last update 20 Mar 2025
Interferon alfa-2b(Nautilus Biotech SA)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Interferons, Biosimilar |
Synonyms HL-031 (oral interferon alpha-2b)-HanAll Biopharma, HL-143 (subcutaneous interferon alpha-2b)-HanAll Biopharma, Hanferon + [4] |
Target |
Action agonists, stimulants, inducers |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Login to view timeline
Structure/Sequence
Sequence Code 26333714
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Interferon alfa-2b(Nautilus Biotech SA)NCT01194037
A Phase 1b/2a, Open-label,Randomized, Safety, Tolerability, Dose Finding, Pharmacokinetic/Pharmacodynamic, and Preliminary Efficacy Study of Subcutaneous Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C
EUCTR2008-006208-52-DE
Mono-centre, open-label study to investigate the multi-dose pharmacokinetics, efficacy and safety of Interferon alpha-2b Cream in women with a history of cytological diagnosed Pap IIID, with a confirmed histological diagnosis of CIN I or II, and of confirmed HPV+ status - Interferon alpha-2b kinetics in Pap IIID women
100 Clinical Results associated with Interferon alfa-2b(Nautilus Biotech SA)
Login to view more data
100 Translational Medicine associated with Interferon alfa-2b(Nautilus Biotech SA)
Login to view more data
100 Patents (Medical) associated with Interferon alfa-2b(Nautilus Biotech SA)
Login to view more data
100 Deals associated with Interferon alfa-2b(Nautilus Biotech SA)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Interferon alfa-2b(Nautilus Biotech SA) | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis C | Phase 2 | - | - | |
| Hepatocellular Carcinoma | Phase 2 | - | - | |
| Chronic hepatitis C genotype 1 | Discovery | United States | 01 Jun 2011 | |
| Hepatitis C, Chronic | Discovery | United States | 01 Jun 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free